Review: Interventions Can Cut Inappropriate Cardiac Imaging

This article originally appeared here.
Share this content:
Review: Interventions Can Cut Inappropriate Cardiac Imaging
Review: Interventions Can Cut Inappropriate Cardiac Imaging

WEDNESDAY, Jan. 6, 2016 (HealthDay News) -- Quality improvement interventions that employ physician audit and feedback can reduce inappropriate cardiac imaging, according to a review published online Jan. 5 in Circulation: Cardiovascular Quality and Outcomes.

Dipayan Chaudhuri, from McMaster University in Hamilton, Canada, and colleagues conducted a systematic review of studies assessing quality improvement initiatives aimed at reducing inappropriate cardiovascular imaging. Data were included from six observational studies and one randomized control trial. Six of the interventions had a formal education component and five included a mechanism for audit and feedback for physicians.

The researchers found that the odds of inappropriate testing were reduced with interventions (odds ratio [OR], 0.44; 95 percent confidence interval [CI], 0.32 to 0.61), with significant heterogeneity observed (I² = 70 percent); the reduction was best explained by the use of physician audit and feedback. The odds of inappropriate testing were reduced significantly with interventions that employed physician audit and feedback (OR, 0.36; 95 percent CI, 0.31 to 0.41), whereas interventions without this component had no effect (OR, 0.89; 95 percent CI, 0.61 to 1.29).

"Interventions using physician audit and feedback are associated with lower odds of inappropriate cardiac testing," the authors write. "Further research is needed to evaluate a greater diversity of intervention types, with improved study designs."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »